Is concern about cardiovascular events with the new coxib class of drugs justified?

T. J. Schnitzer^*

^*Corresponding author for this work

Physical Medicine and Rehabilitation

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Number of pages	1
Journal	Medscape women's health
Volume	6
Issue number	5
State	Published - Jan 1 2001

ASJC Scopus subject areas

Medicine(all)

Other files and links

Cite this

@article{a010270e21894c52b932ee82133c7d27,

title = "Is concern about cardiovascular events with the new coxib class of drugs justified?",

author = "Schnitzer, {T. J.}",

year = "2001",

month = jan,

day = "1",

language = "English (US)",

volume = "6",

journal = "Medscape women's health",

issn = "1521-2076",

publisher = "Medscape Health Network",

number = "5",

}

TY - JOUR

T1 - Is concern about cardiovascular events with the new coxib class of drugs justified?

AU - Schnitzer, T. J.

PY - 2001/1/1

Y1 - 2001/1/1

UR - http://www.scopus.com/inward/record.url?scp=18544403868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544403868&partnerID=8YFLogxK

M3 - Editorial

C2 - 11698930

AN - SCOPUS:18544403868

VL - 6

JO - Medscape women's health

JF - Medscape women's health

SN - 1521-2076

IS - 5

ER -